HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
1.030
-0.050 (-4.63%)
At close: Apr 1, 2025, 4:00 PM
1.039
+0.009 (0.84%)
After-hours: Apr 1, 2025, 6:19 PM EDT
HOOKIPA Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
Cash & Equivalents | 39.68 | 117.1 | 112.49 | 65.92 | 142.74 | Upgrade
|
Cash & Short-Term Investments | 39.68 | 117.1 | 112.49 | 65.92 | 142.74 | Upgrade
|
Cash Growth | -66.11% | 4.10% | 70.64% | -53.82% | 26.15% | Upgrade
|
Accounts Receivable | 0.29 | 0.51 | 6.53 | 6.9 | 5.54 | Upgrade
|
Other Receivables | 23.38 | 18.76 | 15.48 | 14.27 | 15.12 | Upgrade
|
Receivables | 23.67 | 19.27 | 22.01 | 21.17 | 20.66 | Upgrade
|
Prepaid Expenses | 15 | 10.75 | 12.16 | 14.48 | 8.1 | Upgrade
|
Restricted Cash | 0.1 | - | 0.54 | 0.57 | - | Upgrade
|
Other Current Assets | 2.22 | - | - | - | - | Upgrade
|
Total Current Assets | 80.67 | 147.12 | 147.2 | 102.14 | 171.5 | Upgrade
|
Property, Plant & Equipment | 1.06 | 13.22 | 21.98 | 22.12 | 13.97 | Upgrade
|
Other Long-Term Assets | 0.82 | 1.01 | 1.28 | 1.8 | 2.34 | Upgrade
|
Total Assets | 82.55 | 161.34 | 170.45 | 126.05 | 187.82 | Upgrade
|
Accounts Payable | 8.69 | 12.5 | 5.49 | 8.76 | 8.01 | Upgrade
|
Accrued Expenses | 9.81 | 11.67 | 10.65 | 8.16 | 6.35 | Upgrade
|
Current Portion of Long-Term Debt | - | 1.12 | 1.59 | 2.79 | - | Upgrade
|
Current Portion of Leases | 0.55 | 1.64 | 1.69 | 1.7 | 2.15 | Upgrade
|
Current Income Taxes Payable | - | 0.37 | 0.23 | - | - | Upgrade
|
Current Unearned Revenue | 4.76 | 14.68 | 15.98 | 6.23 | 4.63 | Upgrade
|
Other Current Liabilities | 0.84 | 0.01 | - | 0.01 | - | Upgrade
|
Total Current Liabilities | 24.65 | 41.99 | 35.63 | 27.65 | 21.14 | Upgrade
|
Long-Term Debt | - | - | 0.91 | 2.22 | 4.54 | Upgrade
|
Long-Term Leases | 0.32 | 3.8 | 2.31 | 3.91 | 4.08 | Upgrade
|
Long-Term Unearned Revenue | 0.73 | 19.67 | 25.66 | 0.02 | 0.78 | Upgrade
|
Other Long-Term Liabilities | 5.63 | 6.02 | 3.42 | 2.65 | 1.15 | Upgrade
|
Total Liabilities | 31.33 | 71.48 | 67.94 | 36.45 | 31.69 | Upgrade
|
Common Stock | 0 | 0 | 0.01 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 469.06 | 467.05 | 397.35 | 317.14 | 309.29 | Upgrade
|
Retained Earnings | -412.76 | -369.26 | -287.68 | -222.77 | -147.1 | Upgrade
|
Comprehensive Income & Other | -5.09 | -7.93 | -7.16 | -4.78 | -6.07 | Upgrade
|
Total Common Equity | 51.21 | 89.86 | 102.52 | 89.59 | 156.12 | Upgrade
|
Shareholders' Equity | 51.21 | 89.86 | 102.52 | 89.59 | 156.12 | Upgrade
|
Total Liabilities & Equity | 82.55 | 161.34 | 170.45 | 126.05 | 187.82 | Upgrade
|
Total Debt | 0.88 | 6.56 | 6.5 | 10.63 | 10.77 | Upgrade
|
Net Cash (Debt) | 38.81 | 110.54 | 105.99 | 55.3 | 131.98 | Upgrade
|
Net Cash Growth | -64.89% | 4.29% | 91.67% | -58.10% | 30.93% | Upgrade
|
Net Cash Per Share | 3.10 | 11.69 | 16.18 | 16.84 | 50.68 | Upgrade
|
Filing Date Shares Outstanding | 12.54 | 12.54 | 7.22 | 5.64 | 2.98 | Upgrade
|
Total Common Shares Outstanding | 12.54 | 12.54 | 7.22 | 3.29 | 2.98 | Upgrade
|
Working Capital | 56.01 | 105.13 | 111.56 | 74.48 | 150.36 | Upgrade
|
Book Value Per Share | 4.08 | 7.17 | 14.20 | 27.23 | 52.45 | Upgrade
|
Tangible Book Value | 51.21 | 89.86 | 102.52 | 89.59 | 156.12 | Upgrade
|
Tangible Book Value Per Share | 4.08 | 7.17 | 14.20 | 27.23 | 52.45 | Upgrade
|
Land | - | 2.03 | 1.96 | 2.07 | - | Upgrade
|
Machinery | 2.96 | 12.03 | 10.06 | 9.55 | 7.97 | Upgrade
|
Construction In Progress | 0.01 | 0.21 | 10.57 | 7.75 | 0.03 | Upgrade
|
Leasehold Improvements | 3.1 | 3.3 | 3.16 | 3.35 | 3.32 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.